Loading…

Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts

Background Clinical guidelines for the prevention of opportunistic infections in human immunodeficiency virus (HIV)-infected individuals have been developed on the basis of natural history data collected in the USA. The objective of this study was to estimate the incidence of primary opportunistic i...

Full description

Saved in:
Bibliographic Details
Published in:International journal of epidemiology 2001-08, Vol.30 (4), p.864-871
Main Authors: Yazdanpanah, Yazdan, Chêne, Geneviève, Losina, Elena, Goldie, Sue J, Merchadou, Laurence Dequae, Alfandari, Serge, Seage, George R, Sullivan, Lisa, Marimoutou, Catherine, Paltiel, A David, Salamon, Roger, Mouton, Yves, Freedberg, Kenneth A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Clinical guidelines for the prevention of opportunistic infections in human immunodeficiency virus (HIV)-infected individuals have been developed on the basis of natural history data collected in the USA. The objective of this study was to estimate the incidence of primary opportunistic infections in HIV-infected individuals in geographically distinct cohorts in France. Methods We conducted our study on 2664 HIV-infected patients from the Tourcoing AIDS Reference Centre and the hospital-based information system of the Groupe d'Epidémiologie Clinique du SIDA en Aquitaine enrolled from January 1987 to September 1995 and followed through December 1995. We estimated: (1) CD4-adjusted incidence rates of seven primary opportunistic infections in the absence of prophylaxis for that specific infection or any antiretroviral drugs other than zidovudine; and (2) CD4 lymphocyte count decline. Results The highest incidence rates for all opportunistic infections studied occurred in patients with CD4 counts
ISSN:0300-5771
1464-3685
DOI:10.1093/ije/30.4.864